# Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging

> **NCT06639828** · PHASE4 · RECRUITING · sponsor: **GE Healthcare** · enrollment: 50 (estimated)

## Conditions studied

- Focal Liver Lesions

## Interventions

- **DIAGNOSTIC_TEST:** Contrast-Enhanced Ultrasound

## Key facts

- **NCT ID:** NCT06639828
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-20
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06639828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06639828, "Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06639828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*